Sujay Kango Acceleron Pharma Inc (XLRN) insider trading activity

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held N/A

SUJAY KANGO Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 19 2021	SELL Disposition due to a tender of shares in a change of control transaction	-	18,509 Reduced 100.0%	0 Common Stock
Sep 27 2021	SELL Open market or private sale	$875,000 $175.0 p/Share	5,000 Reduced 21.27%	18,509 Common Stock
Sep 27 2021	BUY Exercise of conversion of derivative security	$203,050 $40.61 p/Share	5,000 Added 17.54%	23,509 Common Stock
Sep 21 2021	SELL Open market or private sale	$750,150 $150.03 p/Share	5,000 Reduced 21.27%	18,509 Common Stock
Sep 21 2021	BUY Exercise of conversion of derivative security	$203,050 $40.61 p/Share	5,000 Added 17.54%	23,509 Common Stock
Mar 02 2021	SELL Open market or private sale	$683,750 $136.75 p/Share	5,000 Reduced 20.5%	19,396 Common Stock
Mar 02 2021	BUY Exercise of conversion of derivative security	$203,050 $40.61 p/Share	5,000 Added 17.01%	24,396 Common Stock
Feb 12 2021	SELL Payment of exercise price or tax liability	$116,082 $130.87 p/Share	887 Reduced 4.57%	18,509 Common Stock
Jan 29 2021	BUY Grant, award, or other acquisition	-	5,409 Added 21.81%	19,396 Common Stock
Jan 04 2021	SELL Open market or private sale	$1,250,700 $125.07 p/Share	10,000 Reduced 71.49%	3,987 Common Stock
Jan 04 2021	SELL Payment of exercise price or tax liability	$168,689 $124.31 p/Share	1,357 Reduced 8.84%	13,987 Common Stock

MEIP

MEI Pharma, Inc. Healthcare

INFI

INFINITY PHARMACEUTICALS, INC. Healthcare

EVP, Chief Commercial Officer

San Diego, CA

Receive a notification when an Institution or Guru buys or sells XLRN shares.

Notify only if

Value

Get notified when an Acceleron Pharma Inc insider buys or sells XLRN shares.

Notify only if

Operation

Value

Type

Receive news related to ACCELERON PHARMA INC